INSM – insmed incorporated (US:NASDAQ)

News

Insmed Incorporated (INSM) PT Lifted to $230 as Guggenheim Updates Biotech Earnings Models [Yahoo! Finance]
How The Insmed (INSM) Investment Story Is Shifting On Brinsupri And ENCORE Developments [Yahoo! Finance]
Insmed to Host First-Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026
Insmed (INSM) had its "buy" rating reaffirmed by Roth Mkm. They now have a $212.00 price target on the stock.
Insmed (INSM) had its "buy" rating reaffirmed by Guggenheim.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com